Citius Pharmaceuticals, Inc. Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements
Citius Pharmaceuticals, Inc. (CTXR) reported Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements of 201.33 thousand shares for the 6-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements · last filed 2020-05-14
- Citius Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2019-12-31 was 201.33K shares, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2018-12-31 was 201.33K shares, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2017-12-31 was 201.33K shares.
- Citius Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of equity unit purchase agreements for fiscal 2019 was 201.33K shares, a 0.00% change from fiscal 2018.
- Citius Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of equity unit purchase agreements for fiscal 2018 was 201.33K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 12 month |
|---|---|---|---|---|
| 2020-03-31 | 201.33K shares 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | 201.33K shares 10-Q · filed 2020-02-13 | |||
| 2019-09-30 | 201.33K shares 10-K · filed 2019-12-16 | |||
| 2019-06-30 | 201.33K shares 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | 201.33K shares 10-Q · filed 2019-05-15 | |||
| 2018-12-31 | 201.33K shares 10-Q · filed 2019-02-14 | |||
| 2018-09-30 | 201.33K shares 10-K · filed 2018-12-11 | |||
| 2018-06-30 | 201.33K shares 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | 201.33K shares 10-Q · filed 2018-05-11 | |||
| 2017-12-31 | 201.33K shares 10-Q · filed 2018-02-14 | |||
| 2017-09-30 | 201.33K shares 10-Q · filed 2018-08-14 | |||
| 2017-06-30 | 201.33K shares 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |